Literature DB >> 24932691

Febuxostat in adenosine phosphoribosyltransferase deficiency.

Margrét Arnadóttir1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24932691     DOI: 10.1053/j.ajkd.2014.04.026

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  5 in total

1.  Early Recognition and Management of Rare Kidney Stone Disorders.

Authors:  Boss Goldstein; David S Goldfarb
Journal:  Urol Nurs       Date:  2017 Mar-Apr

2.  APRT deficiency: the need for early diagnosis.

Authors:  Aamira Huq; Kushma Nand; Rajiv Juneja; Ingrid Winship
Journal:  BMJ Case Rep       Date:  2018-10-23

3.  Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial.

Authors:  Vidar O Edvardsson; Hrafnhildur L Runolfsdottir; Unnur A Thorsteinsdottir; Inger M Sch Agustsdottir; G Steinunn Oddsdottir; Finnur Eiriksson; David S Goldfarb; Margret Thorsteinsdottir; Runolfur Palsson
Journal:  Eur J Intern Med       Date:  2017-12-12       Impact factor: 4.487

4.  Adenine phosphoribosyl transferase deficiency leads to renal allograft dysfunction in kidney transplant recipients: a systematic review.

Authors:  Ishfaq Rashid; Ashish Verma; Pramil Tiwari; Sanjay D'Cruz
Journal:  J Bras Nefrol       Date:  2022 Jul-Sep

Review 5.  Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria.

Authors:  Guillaume Bollée; Pierre Cochat; Michel Daudon
Journal:  Can J Kidney Health Dis       Date:  2015-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.